Search

Dr Prantik Das 06084584

Clinical oncology

  • Fee assured
Overview

Specialises in

  • Hepatobiliary
  • Upper GI
  • Urology

Offers

  • Home chemotherapy

About me

Dr Prantik Das completed basic medical training in the UK and awarded MRCP in 2009.He subsequently joined Clinical Oncology training programme in Northern Ireland deanery. During his training, he obtained a postgraduate diploma from the University of London in Oncology. After completion of his FRCR in 2013, he went for Proton Therapy Fellowship at University of Florida, USA. He is very interested in hypofractionated radiotherapy as a means to escalate radiation dose to tumours and improve outcomes for men with locally advanced prostate cancer. This radiotherapy can be optimally delivered with High Dose Rate brachytherapy or with Image Guided Stereotactic Ablative Radiotherapy (SABR).

Dr Das has been actively involved in various national and international clinical trials( STAMPEDE, SOURCE, CASSIOPE, POUT, ATLAS, AQUARIAS, PAZO2, KEYNOTE 811
PLATFORM, SCOPE 2, RADICALS, ACE,
STAR )as Principal investigator .
He is a first author of a number of publications in peer-reviewed journals and also worked as reviewer in international journal. He has also contributed as author of Pocket Guide to Human Tumors and Cancer by CRC press USA.

Areas of interest

Prostate, Kidney, bladder, penis, testicular cancer oesophageal, stomach cancer , pancreas, gall bladder, neuroendocrine cancer, small bowel , and lung cancer
Radiotherapy: MR linac , Stereotactic radiotherapy (SBRT) ,SPACE OAR ,3 D conformal radiotherapy, Intensity Modulated Radiotherapy(IMRT) along with IGRT
Immunotherapy, Chemotherapy, biological therapy and novel anticancer therapy

Medical secretaries

About me
My outcomes
My qualifications & training
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0002

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (5-50)

    Nuffield Health Derby Hospital (5-50)

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)

    Nuffield Health Derby Hospital (5-50)

  • A0380

    Stereotactic radiotherapy (SRT) using GammaKnife or similar SRT technology - (1-5)

    GenesisCare, Nottingham (1-5)

  • A1070

    Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (1-5)

    GenesisCare, Nottingham (1-5)

  • A1080

    Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (1-5)

    GenesisCare, Nottingham (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.